Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02107105 · ClinicalTrials.gov registry record

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
430
Enrollment target

NCT02107105: Recruiting study, sponsored by M.D. Anderson Cancer Center.

NCT02107105 is a clinical trial that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 430 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02107105 is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
430 participants
Enrollment target

Study Summary

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

Primary Outcome

A health state utility is the degree of preference that individuals or society has for a particular health state or condition.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2014-05-16
Est. Completion 2030-05-31
M.D. Anderson Cancer Center

2,692 total trials

What NCT02107105 shows while recruiting

NCT02107105 is an observational study that tracks outcomes without assigning an intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.

NCT02107105 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02107105 about?

NCT02107105 is a clinical study titled "Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer". This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

What is the current status of trial NCT02107105?

This trial is currently recruiting. The enrollment target is 430 participants. The study started on 2014-05-16. Estimated completion is 2030-05-31.

What interventions are being tested in trial NCT02107105?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT02107105?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05327023 · 430 participants · Phase 1

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  • NCT05457985 · 430 participants · NA

    Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

  • NCT05532982 · 430 participants

    Parkinson's Disease in Asian Americans

  • NCT05844891 · 430 participants · NA

    Telehealth-Enhanced Asthma Care for Home After the Emergency Room

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02107105, the US trial registry maintained by the National Library of Medicine. NCT02107105 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.